Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers

European Journal of Neurology

Volumn 16, Issue 1, 2009, Pages 95-100

  Kehoe, A D ^a   Nikiforov, A M ^b   Alexanin, S S ^b   Neronov, E G ^b   Tikhomirova, O V ^b   Shun'Kov, V B ^b   Makarova, N V ^b   Rabinovich, E ^b   Usmanova, N M ^c   Kazakov, V I ^c   Slozina, N M ^b   Montgomery, H E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b All Russian Centre of Emergency and Radiation Medicine   (Russian Federation)

^c INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

ACE; Angiotensin; Chernobyl cleanup workers; Encephalopathy; Polymorphism; Radiation

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN DISEASE; CHERNOBYL ACCIDENT; CHERNOBYL CLEANUP WORKER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DYSCIRCULATORY ENCEPHALOPATHY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; WORKER;

CHERNOBYL NUCLEAR ACCIDENT; COHORT STUDIES; DEMENTIA, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RADIATION INJURIES; RADIOACTIVE HAZARD RELEASE; RANDOM ALLOCATION;

EID: 57449083795     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02355.x     Document Type: Article

References (58)

1. UNSCEAR 2000 Report to the General Assembly with scientific annexes. Sources and Effects of Ionizing Radiation. Vol II: Effects, Annex J: Exposures and Effects of the Chernobyl Accident. Geneva : United Nations Publications. 2000.
2. Loganovsky K, Havenaar JM, Tintle NL, Guey LT, Kotov R, Bromet EJ. The mental health of clean-up workers 18 years after the Chernobyl accident. Psychological Medicine 2008 38 : 481 488.
3. Ivanov VK, Maksioutov MA, Chekin SY, et al. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Physics 2006 90 : 199 207.
4. Skoromet AA, Nikiforov AM. Diagnosis and Principles of Therapy of Dyscirculatory Encephalopathy. [in Russian]. St. Petersburg : ELBY-SPB, 2005.
5. Vashchenko EA, Nyagu AI, Brous BA, Vasilenko DA. State of the autonomic reflex mechanisms in humans subjected to irradiation because of the Chernobyl' catastrophe. Neurophysiology 1998 30 : 3 17.
6. Kharchenko VP, Zubovskii GA, Kholodova NB. Diagnostics and Treatment of Neurological Diseases in Persons Involved in the Cleanup Works After the Chernobyt NPS Catastrophe, Methodological Recommendations. [in Russian]. Moscow : Moscow Research Institute for Diagnostics and Surgery, Ministry of Medicine-Related Industry of Russian Federation. 1994.
7. Robbins ME, Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. International Journal of Radiation Oncology, Biology, Physics 2006 64 : 6 12.
8. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2003 285 : R498 R511.
9. Ariza M, Matarin MD, Junque C, et al. Influence of angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences 2006 18 : 39 44.
10. Baranov D, Armstead WM. Selective blockade of AT1 receptor attenuates impairment of hypotensive autoregulation and improves cerebral blood flow after brain injury in the newborn pig. Anesthesiology 2003 99 : 1118 1124.
11. Li J, Culman J, Hortnagl H, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB Journal 2005 19 : 617 619.
12. Kim JH, Brown SL, Kolozsvary A, et al. Modification of radiation injury by ramipril, inhibitor of angiotensin-converting enzyme, on optic neuropathy in the rat. Radiation Research 2004 161 : 137 142.
13. Costerousse O, Allegrini J, Huang W, henc-Gelas F. Angiotensin I-converting enzyme (kininase II) in cardiovascular and renal regulations and diseases. Biological Research 1998 31 : 161 167.
14. Danser AH, Schunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. European Journal of Pharmacology 2000 410 : 303 316.
15. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32 500 individuals. PLoS Medicine 2007 4 : e131.
16. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. Journal of Neurology, Neurosurgery and Psychiatry 1998 64 : 227 230.
17. Richard F, Berr C, Amant C, Helbecque N, Amouyel P, Alperovitch A. Effect of the angiotensin I-converting enzyme ID polymorphism on cognitive decline. The EVA Study Group. Neurobiology of Aging 2000 21 : 75 80.
18. Illi A, Kampman O, Anttila S, et al. Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. European Neuropsychopharmacology 2003 13 : 147 151.
19. O'Dell SD, Humphries SE, Day IN. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. British Heart Journal 1995 73 : 368 371.
20. Stornetta RL, Hawelu-Johnson CL, Guyenet PG, Lynch KR. Astrocytes synthesize angiotensinogen in brain. Science 1988 242 : 1444 1446.
21. Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circulation Research 1998 83 : 1047 1058.
22. Yang G, Gray TS, Sigmund CD, Cassell MD. The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Research 1999 817 : 123 131.
23. McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, Oldfield BJ. Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clinical and Experimental Pharmacology and Physiology. Supplement 1996 3 : S99 S104.
24. Johnson AK, Thunhorst RL. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Frontiers in Neuroendocrinology 1997 18 : 292 353.
25. Johnson AK, Cunningham JT, Thunhorst RL. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clinical and Experimental Pharmacology and Physiology 1996 23 : 183 191.
26. Miselis RR. The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance. Brain Research 1981 230 : 1 23.
27. Eng R, Miselis RR. Polydipsia and abolition of angiotensin-induced drinking after transections of subfornical organ efferent projections in the rat. Brain Research 1981 225 : 200 206.
28. Gutman MB, Ciriello J, Mogenson GJ. Effect of paraventricular nucleus lesions on cardiovascular responses elicited by stimulation of the subfornical organ in the rat. Canadian Journal of Physiology and Pharmacology 1985 63 : 816 824.
29. Lazartigues E, Dunlay SM, Loihl AK, et al. Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circulation Research 2002 90 : 617 624.
30. Barnes JM, Barnes NM, Costall B, et al. Angiotensin-converting enzyme inhibition, angiotensin, and cognition. Journal of Cardiovascular Pharmacology 1992 19 (Suppl. 6 S63 S71.
31. Raghavendra V, Chopra K, Kulkarni SK. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides 1998 32 : 417 421.
32. Raghavendra V, Chopra K, Kulkarni SK. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 2001 35 : 65 69.
33. Germain L, Chouinard G. Captopril treatment of major depression with serial measurements of blood cortisol concentrations. Biological Psychiatry 1989 25 : 489 493.
34. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. New England Journal of Medicine 1986 314 : 1657 1664.
35. Tedesco MA, Ratti G, Di SG, Natale F. Does the angiotensin II receptor antagonist losartan improve cognitive function? Drugs and Aging 2002 19 : 723 732.
36. Nataraj C, Oliverio MI, Mannon RB, et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. Journal of Clinical Investigation 1999 104 : 1693 1701.
37. Schulz R, Heusch G. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation. Journal of Hypertension. Supplement 2006 24 : S123 S129.
38. Jung KH, Chu K, Lee ST, et al. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. Journal of Pharmacology and Experimental Therapeutics 2007 322 : 1051 1058.
39. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. Journal of Neuroscience 1997 17 : 2653 2657.
40. Robbins ME, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. International Journal of Radiation Biology 2004 80 : 251 259.
41. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain, Behavior, and Immunity 2002 16 : 622 653.
42. Baghai TC, Schule C, Zwanzger P, et al. Hypothalamic-pituitary- adrenocortical axis dysregulation in patients with major depression is influenced by the insertiondeletion polymorphism in the angiotensin I-converting enzyme gene. Neuroscience Letters 2002 328 : 299 303.
43. Arinami T, Li L, Mitsushio H, Itokawa M, Hamaguchi H, Toru M. An insertiondeletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biological Psychiatry 1996 40 : 1122 1127.
44. Uemura K, Kohara K, Nakura J, Miki T. Deletion polymorphism of ACE gene is associated with higher blood pressure after hospitalization in normotensive subjects. Hypertension Research 2000 23 : 201 205.
45. Rodd ZA, Bertsch BA, Strother WN, et al. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. The Pharmacogenomics Journal 2007 7 : 222 256.
46. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. Journal of Clinical Oncology 1994 12 : 627 642.
47. Vigliani MC, Duyckaerts C, Hauw JJ, Poisson M, Magdelenat H, Delattre JY. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. Journal of Neuro-Oncology 1999 41 : 137 149.
48. Coderre JA, Morris GM, Micca PL, et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiation Research 2006 166 : 495 503.
49. Yoneoka Y, Satoh M, Akiyama K, Sano K, Fujii Y, Tanaka Y. An experimental study of radiation-induced cognitive dysfunction in an adult rat model. British Journal of Radiology 1999 72 : 1196 1201.
50. Moretti R, Torre P, Antonello RM, et al. Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. Journal of the Neurological Sciences 2005 229-230 : 195 200.
51. Loganovsky KN, Yuryev KL. EEG patterns in persons exposed to ionizing radiation as a result of the Chernobyl accident: part 1: conventional EEG analysis. Journal of Neuropsychiatry and Clinical Neurosciences 2001 13 : 441 458.
52. Molteni A, Moulder JE, Cohen EF, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. International Journal of Radiation Biology 2000 76 : 523 532.
53. Moulder JE, Fish BL, Cohen EP. Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy. International Journal of Radiation Biology 1998 73 : 415 421.
54. Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Seminars in Radiation Oncology 2007 17 : 141 148.
55. Skvortsova VI, Platonova IA, Tvorogova TV, Volkovenko OV, Demidova LI, Ostrovtsev IV. The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy. Neuroscience and Behavioral Physiology 2004 34 : 939 947.
56. Macheret I, Khanenko NV. Drug therapy of patients with dyscirculatory encephalopathy. Likars'ka Sprava 2002 3-4 : 84 87.
57. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiation Research 1999 152 : 374 389.
58. Yamada M, Sasaki H, Kasagi F, et al. Study of cognitive function among the Adult Health Study (AHS) population in Hiroshima and Nagasaki. Radiation Research 2002 158 : 236 240.